CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: EC 3.5.2.* (non-peptide cyclic amide C-N hydrolase) inhibitor
Accession: CHEBI:76808
browse the term
Definition: An EC 3.5.* (hydrolases acting on non-peptide C-N bonds) inhibitor that interferes with the action of any non-peptide cyclic amide C-N hydrolase (EC 3.5.2.*).
Synonyms: related_synonym: EC 3.5.2.* inhibitor; EC 3.5.2.* inhibitors; non-peptide cyclic amide C-N hydrolase (EC 3.5.2.*) inhibitors; non-peptide cyclic amide C-N hydrolase inhibitor; non-peptide cyclic amide C-N hydrolase inhibitors
G
Abcb11
ATP-binding cassette, sub-family B member 11
decreases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in decreased expression of ABCB11 mRNA
CTD
PMID:34767876
NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,960
G
Akr1b10
aldo-keto reductase family 1, member B10
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of AKR1B10 mRNA
CTD
PMID:34767876
NCBI chr 6:34,361,182...34,373,884
Ensembl chr 6:34,361,153...34,373,885
G
Casp3
caspase 3
increases activity
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased activity of CASP3 protein
CTD
PMID:30273099
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp9
caspase 9
increases activity
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased activity of CASP9 protein
CTD
PMID:30273099
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
G
Cxcl15
C-X-C motif chemokine ligand 15
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of CXCL8 protein
CTD
PMID:11390425
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Cycs
cytochrome c, somatic
increases secretion
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased secretion of CYCS protein
CTD
PMID:30273099
NCBI chr 6:50,539,543...50,543,549
Ensembl chr 6:50,539,543...50,543,518
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
decreases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP27A1 mRNA
CTD
PMID:34767876
NCBI chr 1:74,752,311...74,777,056
Ensembl chr 1:74,752,733...74,777,051
G
Cyp7a1
cytochrome P450, family 7, subfamily a, polypeptide 1
decreases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP7A1 mRNA
CTD
PMID:34767876
NCBI chr 4:6,265,612...6,275,632
Ensembl chr 4:6,265,612...6,275,633
G
Cyp8b1
cytochrome P450, family 8, subfamily b, polypeptide 1
decreases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP8B1 mRNA
CTD
PMID:34767876
NCBI chr 9:121,743,422...121,745,371
Ensembl chr 9:121,743,422...121,745,371
G
Fgf15
fibroblast growth factor 15
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of FGF19 mRNA
CTD
PMID:34767876
NCBI chr 7:144,450,269...144,454,690
Ensembl chr 7:144,450,268...144,454,690
G
G6pdx
glucose-6-phosphate dehydrogenase X-linked
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of G6PD mRNA
CTD
PMID:34767876
NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of GCLC mRNA
CTD
PMID:34767876
NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
G
Gclm
glutamate-cysteine ligase, modifier subunit
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of GCLM mRNA
CTD
PMID:34767876
NCBI chr 3:122,039,206...122,060,864
Ensembl chr 3:122,039,206...122,064,381
G
Ggt1
gamma-glutamyltransferase 1
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of GGT1 protein
CTD
PMID:34767876
NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034
G
Got1
glutamic-oxaloacetic transaminase 1, soluble
increases activity
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased activity of GOT1 protein
CTD
PMID:30273099
NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
G
Gpt
glutamic pyruvic transaminase, soluble
increases activity
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased activity of GPT protein
CTD
PMID:30273099
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
G
Gpx2
glutathione peroxidase 2
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of GPX2 mRNA
CTD
PMID:34767876
NCBI chr12:76,839,109...76,842,328
Ensembl chr12:76,839,107...76,842,273
G
Gsr
glutathione reductase
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of GSR mRNA
CTD
PMID:34767876
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Me1
malic enzyme 1, NADP(+)-dependent, cytosolic
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of ME1 mRNA
CTD
PMID:34767876
NCBI chr 9:86,463,416...86,577,967
Ensembl chr 9:86,463,424...86,578,006
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of NR0B2 mRNA
CTD
PMID:34767876
NCBI chr 4:133,280,687...133,283,997
Ensembl chr 4:133,280,687...133,283,847
G
Slc10a1
solute carrier family 10 (sodium/bile acid cotransporter family), member 1
decreases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in decreased expression of SLC10A1 mRNA
CTD
PMID:34767876
NCBI chr12:80,999,959...81,015,479
Ensembl chr12:80,999,957...81,015,479
G
Slc51a
solute carrier family 51, alpha subunit
decreases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in decreased expression of SLC51A mRNA
CTD
PMID:34767876
NCBI chr16:32,294,396...32,306,697
Ensembl chr16:32,293,322...32,306,697
G
Slc7a11
solute carrier family 7 (cationic amino acid transporter, y+ system), member 11
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of SLC7A11 mRNA
CTD
PMID:34767876
NCBI chr 3:50,319,385...50,403,947
Ensembl chr 3:49,846,975...50,398,063
G
Tkt
transketolase
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of TKT mRNA
CTD
PMID:34767876
NCBI chr14:30,271,088...30,296,681
Ensembl chr14:30,270,316...30,296,677
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
Amoxicillin-Potassium Clavulanate Combination results in increased expression of TXNRD1 mRNA
CTD
PMID:34767876
NCBI chr10:82,669,785...82,733,558
Ensembl chr10:82,669,785...82,733,546
G
Ace2
angiotensin converting enzyme 2
decreases expression
ISO
Ceftriaxone results in decreased expression of ACE2 mRNA
CTD
PMID:29745864
NCBI chr X:162,922,338...162,971,414
Ensembl chr X:162,922,328...162,971,416
G
Actb
actin, beta
increases expression
ISO
Ceftriaxone results in increased expression of ACTB mRNA
CTD
PMID:29745864
NCBI chr 5:142,888,870...142,892,509
Ensembl chr 5:142,888,870...142,892,509
G
Bace1
beta-site APP cleaving enzyme 1
decreases expression
ISO
Ceftriaxone results in decreased expression of BACE1 mRNA
CTD
PMID:29745864
NCBI chr 9:45,749,878...45,775,694
Ensembl chr 9:45,749,878...45,775,697
G
Cat
catalase
decreases expression multiple interactions
EXP ISO
Ceftriaxone results in decreased expression of CAT protein Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of CAT protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of CAT protein]]
CTD
PMID:19442074 PMID:25053526
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Dhfr
dihydrofolate reductase
decreases activity
ISO
Ceftriaxone results in decreased activity of DHFR protein
CTD
PMID:25418905
NCBI chr13:92,491,291...92,525,561
Ensembl chr13:92,491,234...92,525,561
G
Ece1
endothelin converting enzyme 1
increases expression
ISO
Ceftriaxone results in increased expression of ECE1 mRNA
CTD
PMID:29745864
NCBI chr 4:137,589,548...137,692,540
Ensembl chr 4:137,589,548...137,692,540
G
Epo
erythropoietin
increases expression
ISO
Ceftriaxone results in increased expression of EPO mRNA
CTD
PMID:29745864
NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504
G
Ide
insulin degrading enzyme
increases expression
ISO
Ceftriaxone results in increased expression of IDE mRNA
CTD
PMID:29745864
NCBI chr19:37,246,140...37,341,664
Ensembl chr19:37,246,142...37,340,010
G
Il1b
interleukin 1 beta
multiple interactions
ISO
Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]]
CTD
PMID:25053526
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Mme
membrane metallo endopeptidase
increases expression
ISO
Ceftriaxone results in increased expression of MME mRNA
CTD
PMID:29745864
NCBI chr 3:63,202,632...63,291,134
Ensembl chr 3:63,148,958...63,293,451
G
Slc1a2
solute carrier family 1 (glial high affinity glutamate transporter), member 2
multiple interactions increases expression
ISO
Ceftriaxone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of SLC1A2 protein]; Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC1A2 protein]; Ceftriaxone inhibits the reaction [JZL195 results in decreased expression of and affects the folding of SLC1A2 protein]; Ceftriaxone promotes the reaction [Kainic Acid results in increased expression of SLC1A2 protein] Ceftriaxone results in increased expression of SLC1A2 protein
CTD
PMID:19625514 PMID:19717140 PMID:28257918 PMID:29045497 PMID:29432698
NCBI chr 2:102,488,584...102,621,129
Ensembl chr 2:102,489,004...102,621,129
G
Slc7a11
solute carrier family 7 (cationic amino acid transporter, y+ system), member 11
multiple interactions
ISO
Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC7A11 protein]
CTD
PMID:19717140
NCBI chr 3:50,319,385...50,403,947
Ensembl chr 3:49,846,975...50,398,063
G
Tnf
tumor necrosis factor
multiple interactions
ISO
Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF protein]]
CTD
PMID:25053526
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Abcb11
ATP-binding cassette, sub-family B member 11
decreases expression multiple interactions
ISO
Clavulanic Acid results in decreased expression of ABCB11 mRNA Clavulanic Acid inhibits the reaction [GW 4064 results in increased expression of ABCB11 mRNA]
CTD
PMID:34767876
NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,960
G
Abcb4
ATP-binding cassette, sub-family B member 4
decreases expression
ISO
Clavulanic Acid results in decreased expression of ABCB4 mRNA
CTD
PMID:34767876
NCBI chr 5:8,943,614...9,009,226
Ensembl chr 5:8,943,717...9,009,231
G
Abcc2
ATP-binding cassette, sub-family member 2
increases expression
ISO
Clavulanic Acid results in increased expression of ABCC2 mRNA
CTD
PMID:34767876
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
G
Abcg5
ATP binding cassette subfamily G member 5
multiple interactions decreases expression
ISO
Clavulanic Acid inhibits the reaction [GW 4064 results in increased expression of ABCG5 mRNA]; GW 4064 inhibits the reaction [Clavulanic Acid results in decreased expression of ABCG5 mRNA]
CTD
PMID:34767876
NCBI chr17:84,965,602...84,990,439
Ensembl chr17:84,965,662...84,990,439
G
Akr1b10
aldo-keto reductase family 1, member B10
increases expression
ISO
Clavulanic Acid results in increased expression of AKR1B10 mRNA
CTD
PMID:34767876
NCBI chr 6:34,361,182...34,373,884
Ensembl chr 6:34,361,153...34,373,885
G
Cxcl15
C-X-C motif chemokine ligand 15
increases expression decreases expression
ISO
Clavulanic Acid results in increased expression of CXCL8 mRNA Clavulanic Acid results in decreased expression of CXCL8 mRNA
CTD
PMID:32816093
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
decreases expression
ISO
Clavulanic Acid results in decreased expression of CYP27A1 mRNA
CTD
PMID:34767876
NCBI chr 1:74,752,311...74,777,056
Ensembl chr 1:74,752,733...74,777,051
G
Cyp7a1
cytochrome P450, family 7, subfamily a, polypeptide 1
decreases expression
ISO
Clavulanic Acid results in decreased expression of CYP7A1 mRNA
CTD
PMID:34767876
NCBI chr 4:6,265,612...6,275,632
Ensembl chr 4:6,265,612...6,275,633
G
Cyp8b1
cytochrome P450, family 8, subfamily b, polypeptide 1
decreases expression
ISO
Clavulanic Acid results in decreased expression of CYP8B1 mRNA
CTD
PMID:34767876
NCBI chr 9:121,743,422...121,745,371
Ensembl chr 9:121,743,422...121,745,371
G
Ereg
epiregulin
decreases expression increases expression
ISO
Clavulanic Acid results in decreased expression of EREG mRNA Clavulanic Acid results in increased expression of EREG mRNA
CTD
PMID:32816093
NCBI chr 5:91,222,476...91,241,508
Ensembl chr 5:91,222,481...91,241,505
G
Fgf15
fibroblast growth factor 15
increases expression
ISO
Clavulanic Acid results in increased expression of FGF19 mRNA
CTD
PMID:34767876
NCBI chr 7:144,450,269...144,454,690
Ensembl chr 7:144,450,268...144,454,690
G
G6pdx
glucose-6-phosphate dehydrogenase X-linked
increases expression
ISO
Clavulanic Acid results in increased expression of G6PD mRNA
CTD
PMID:34767876
NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
ISO
Clavulanic Acid results in increased expression of GCLC mRNA
CTD
PMID:34767876
NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
G
Gclm
glutamate-cysteine ligase, modifier subunit
increases expression
ISO
Clavulanic Acid results in increased expression of GCLM mRNA
CTD
PMID:34767876
NCBI chr 3:122,039,206...122,060,864
Ensembl chr 3:122,039,206...122,064,381
G
Gpx2
glutathione peroxidase 2
increases expression
ISO
Clavulanic Acid results in increased expression of GPX2 mRNA
CTD
PMID:34767876
NCBI chr12:76,839,109...76,842,328
Ensembl chr12:76,839,107...76,842,273
G
Gsr
glutathione reductase
increases expression
ISO
Clavulanic Acid results in increased expression of GSR mRNA
CTD
PMID:34767876
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Il1a
interleukin 1 alpha
increases expression
ISO
Clavulanic Acid results in increased expression of IL1A mRNA
CTD
PMID:32816093
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
G
Il1b
interleukin 1 beta
increases expression
ISO
Clavulanic Acid results in increased expression of IL1B mRNA
CTD
PMID:32816093
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il24
interleukin 24
increases expression decreases expression
ISO
Clavulanic Acid results in increased expression of IL24 mRNA Clavulanic Acid results in decreased expression of IL24 mRNA
CTD
PMID:32816093
NCBI chr 1:130,809,801...130,815,153
Ensembl chr 1:130,809,811...130,815,191
G
Lss
lanosterol synthase
decreases expression
ISO
Clavulanic Acid results in decreased expression of LSS mRNA
CTD
PMID:34767876
NCBI chr10:76,367,303...76,392,973
Ensembl chr10:76,367,422...76,392,972
G
Me1
malic enzyme 1, NADP(+)-dependent, cytosolic
increases expression
ISO
Clavulanic Acid results in increased expression of ME1 mRNA
CTD
PMID:34767876
NCBI chr 9:86,463,416...86,577,967
Ensembl chr 9:86,463,424...86,578,006
G
Met
met proto-oncogene
increases expression
ISO
Clavulanic Acid results in increased expression of MET mRNA
CTD
PMID:32816093
NCBI chr 6:17,463,351...17,573,979
Ensembl chr 6:17,463,799...17,573,979
G
Mvk
mevalonate kinase
decreases expression
ISO
Clavulanic Acid results in decreased expression of MVK mRNA
CTD
PMID:34767876
NCBI chr 5:114,582,324...114,598,652
Ensembl chr 5:114,582,330...114,598,652
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
increases expression
ISO
Clavulanic Acid results in increased expression of NR0B2 mRNA
CTD
PMID:34767876
NCBI chr 4:133,280,687...133,283,997
Ensembl chr 4:133,280,687...133,283,847
G
Scd2
stearoyl-Coenzyme A desaturase 2
decreases expression
ISO
Clavulanic Acid results in decreased expression of SCD mRNA
CTD
PMID:34767876
NCBI chr19:44,282,115...44,295,303
Ensembl chr19:44,282,113...44,295,303
G
Slc10a1
solute carrier family 10 (sodium/bile acid cotransporter family), member 1
decreases expression
ISO
Clavulanic Acid results in decreased expression of SLC10A1 mRNA
CTD
PMID:34767876
NCBI chr12:80,999,959...81,015,479
Ensembl chr12:80,999,957...81,015,479
G
Slc51a
solute carrier family 51, alpha subunit
multiple interactions decreases expression
ISO
Clavulanic Acid inhibits the reaction [GW 4064 results in increased expression of SLC51A mRNA] Clavulanic Acid results in decreased expression of SLC51A mRNA
CTD
PMID:34767876
NCBI chr16:32,294,396...32,306,697
Ensembl chr16:32,293,322...32,306,697
G
Slc7a11
solute carrier family 7 (cationic amino acid transporter, y+ system), member 11
increases expression decreases expression
ISO
Clavulanic Acid results in increased expression of SLC7A11 mRNA Clavulanic Acid results in decreased expression of SLC7A11 mRNA
CTD
PMID:32816093 PMID:34767876
NCBI chr 3:50,319,385...50,403,947
Ensembl chr 3:49,846,975...50,398,063
G
Slpi
secretory leukocyte peptidase inhibitor
increases expression
ISO
Clavulanic Acid results in increased expression of SLPI mRNA
CTD
PMID:32816093
NCBI chr 2:164,195,990...164,231,086
Ensembl chr 2:164,195,990...164,231,015
G
Srebf1
sterol regulatory element binding transcription factor 1
decreases expression
ISO
Clavulanic Acid results in decreased expression of SREBF1 mRNA
CTD
PMID:34767876
NCBI chr11:60,089,910...60,113,407
Ensembl chr11:60,089,915...60,113,407
G
Tkt
transketolase
increases expression
ISO
Clavulanic Acid results in increased expression of TKT mRNA
CTD
PMID:34767876
NCBI chr14:30,271,088...30,296,681
Ensembl chr14:30,270,316...30,296,677
G
Tnfaip6
tumor necrosis factor alpha induced protein 6
increases expression
ISO
Clavulanic Acid results in increased expression of TNFAIP6 mRNA
CTD
PMID:32816093
NCBI chr 2:51,928,125...51,946,693
Ensembl chr 2:51,928,021...51,946,698
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
Clavulanic Acid results in increased expression of TXNRD1 mRNA
CTD
PMID:34767876
NCBI chr10:82,669,785...82,733,558
Ensembl chr10:82,669,785...82,733,546
G
Il6
interleukin 6
affects expression
ISO
salicylsalicylic acid affects the expression of IL6 protein
CTD
PMID:20876710
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Nos3
nitric oxide synthase 3, endothelial cell
multiple interactions
ISO
salicylsalicylic acid affects the expression of and affects the phosphorylation of NOS3 protein
CTD
PMID:20876710
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
affects expression
ISO
salicylsalicylic acid affects the expression of RELA protein
CTD
PMID:20876710
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Sod2
superoxide dismutase 2, mitochondrial
affects expression
ISO
salicylsalicylic acid affects the expression of SOD2 protein
CTD
PMID:20876710
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Vegfa
vascular endothelial growth factor A
affects expression
ISO
salicylsalicylic acid affects the expression of VEGFA protein
CTD
PMID:20876710
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Il1b
interleukin 1 beta
multiple interactions
ISO
Ozone promotes the reaction [[tazobactam co-treated with Piperacillin] results in increased expression of IL1B mRNA]
CTD
PMID:16369182
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Tnf
tumor necrosis factor
multiple interactions
ISO
Ozone promotes the reaction [[tazobactam co-treated with Piperacillin] results in increased expression of TNF mRNA]
CTD
PMID:16369182
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all